 Ferric Carboxymaltose to Generate nearly 50 of the Intravenous Iron Drugs Market throughout the Analysis Period. The US market for Intravenous Iron Drugs is projected to expand at a CAGR of around 9.3 during 2022 2032. DUBAI, United Arab Emirates, Dec. 07, 2022 GLOBE NEWSWIRE Global Intravenous Iron Drugs Market was valued at ... The post Sales of Intravenous Iron Drugs Market is Estimated to hit US 6.3 Bn at a CAGR of 8.5 by year 2032-end Future Market Insights, Inc. appeared first... 